Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer

被引：6
|
作者：
Wolf, Philipp [1 ,2 ]
机构：
[1] Univ Freiburg, Med Ctr, Dept Urol, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Freiburg, Germany
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
bladder cancer; apoptosis; inhibitor of apoptosis proteins; cIAP1; cIAP2; XIAP; Survivin; Livin; EARLY RECURRENCE; PROGNOSTIC-SIGNIFICANCE; URINARY BIOMARKERS; MELANOMA INHIBITOR; LIGASE ACTIVITY; SMAC MIMETICS; IAP PROTEINS; SURVIVIN; EXPRESSION; LIVIN;
D O I：
10.3389/fonc.2023.1124600
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Evasion from apoptosis is a hallmark of cancer. Inhibitor of apoptosis proteins (IAPs) contribute to this hallmark by suppressing the induction of cell death. IAPs were found to be overexpressed in cancerous tissues and to contribute to therapeutic resistance. The present review focuses on the IAP members cIAP1, cIAP2, XIAP, Survivin and Livin and their importance as potential therapeutic targets in bladder cancer.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] The inhibitor of apoptosis proteins as therapeutic targets in cancer
    Vucic, Domagoj
    Fairbrother, Wayne J.
    CLINICAL CANCER RESEARCH, 2007, 13 (20) : 5995 - 6000
  • [2] Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
    de Graaf, AO
    de Witte, T
    Jansen, JH
    LEUKEMIA, 2004, 18 (11) : 1751 - 1759
  • [3] Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
    A O de Graaf
    T de Witte
    J H Jansen
    Leukemia, 2004, 18 : 1751 - 1759
  • [4] Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma
    V Ramakrishnan
    U Painuly
    T Kimlinger
    J Haug
    S V Rajkumar
    S Kumar
    Leukemia, 2014, 28 : 1519 - 1528
  • [5] Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma
    Ramakrishnan, V.
    Painuly, U.
    Kimlinger, T.
    Haug, J.
    Rajkumar, S. V.
    Kumar, S.
    LEUKEMIA, 2014, 28 (07) : 1519 - 1528
  • [6] Molecular targets for the therapeutic manipulation of apoptosis in bladder cancer
    Duggan, BJ
    Kelly, JD
    Keane, PF
    Johnston, SR
    Williamson, KE
    JOURNAL OF UROLOGY, 2001, 165 (03): : 946 - 954
  • [7] Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic
    Dean, Emma J.
    Ranson, Malcolm
    Blackhall, Fiona
    Holt, Sarah V.
    Dive, Caroline
    CANCER TREATMENT REVIEWS, 2007, 33 (02) : 203 - 212
  • [8] Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies
    S Fulda
    Leukemia, 2012, 26 : 1155 - 1165
  • [9] Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies
    Fulda, S.
    LEUKEMIA, 2012, 26 (06) : 1155 - 1165
  • [10] Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers
    Fulda, Simone
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 760 - 766
12345